Market Overview

Integra Lifesciences Earnings Preview


On Monday, August 10, Integra Lifesciences (NASDAQ: IART) will release its latest earnings report. Benzinga's outlook for Integra Lifesciences is included in the following report.

Earnings and Revenue

Integra Lifesciences EPS is expected to be around $0.1, according to sell-side analysts. Sales will likely be near $242.80 million. In the same quarter last year, Integra Lifesciences reported earnings per share of $0.73 on revenue of $383.64 million. If the company were to report in-line earnings when it publishes results Monday, earnings would be down 86.3%. In comparison to analyst estimates in the past, here's how the company's reported EPS stacks up:

Quarter Q1 2020 Q4 2020 Q3 2019 Q2 2019
EPS Estimate 0.64 0.67 0.65 0.66
EPS Actual 0.48 0.68 0.68 0.73
Revenue Estimate 363.24 M 397.50 M 376.69 M 373.29 M
Revenue Actual 354.32 M 395.13 M 379.10 M 383.64 M

Stock Performance

Over the last 52-week period, shares are down 22.83%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.

Don't be surprised to see the stock move on comments made during its conference call. Integra Lifesciences is scheduled to hold the call at 16:30:00 ET and can be accessed here:


Related Articles (IART)

View Comments and Join the Discussion!

Posted-In: Earnings